Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

• Status: Completed
• Trial end date: 2014-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effect of prophylactic antiglaucoma agents in prevention of acute intraocular pressure rise after intravitreal injection.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mashhad University of Medical Sciences
• Treatments: Acetazolamide; Bevacizumab; Brimonidine Tartrate; Mannitol; Timolol

Criteria

Inclusion Criteria:

• all patients who candidate for receiving intravitreal bevacizumab

Exclusion Criteria:

• patients who had advanced glaucoma

• patients who received antiglaucoma agents in the past

• patients who had corneal scar which affect IOP measurement